🗓 April 20+21 📍Barcelona and online
CHI’s Summit for Clinical Ops Executives Europe (SCOPE Europe), the event that brings together leaders from large, mid-sized, and small pharma, specialty pharma, biotech, vendor companies, and academic research centers who come together to share best practices and discuss the new era of decentralized, analytics-driven and patient-centric trials, will take place in Barcelona and online next week.
The event features four conference tracks, shared plenary keynotes, interactive small breakout discussion groups, panels and networking. Topics to be discussed include the digitalization of trials, decentralized/hybrid trial operations, adapting to COVID, protocol development, global site selection, feasibility, study start up, patient engagement, diversity, enrollment planning, patient recruitment, patient retention, improving site-study activation and performance, new regulations and guidelines, Risk-Based Monitoring (RBM), clinical technology, big data and analytics, Real-World Data (RWD), Artificial Intelligence (AI), biomarker-driven trials, and improving overall quality and speed of clinical trials.
On april 21 Lidia Cánovas, General Manager, Regulatory Affairs at Asphalion will be speaking at the Biocat roundtable “Reimagining Clinical Trials: The Digital Transformation in Catalonia” together with Montserrat Barcelo Riera, MD, Vice President at Veristat, Xavier Cañas, Director of Clinical Trials Promotion and Development at Vall d’Hebron Barcelona Hospital Campus, and Alessandro Monterosso, Director Digital Health Solutions at Alira Health. Moderating the discussion will be Montse D., Scientific Director and International Relations at #Biocat.
For further information have a look at the event website:
SCOPE Europe – Summit for Clinical Ops Executives (scopesummiteurope.com)
